Simplex Trading
TARA icon

Simplex Trading’s Protara Therapeutics TARA Stock Holding History

Simplex Trading’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Sell
30,600
-26,500
-46% -$157K ﹤0.01% 4573
2025
Q4 		$304K Buy
57,100
+56,000
+5,091% +$311K ﹤0.01% 3796
2025
Q3 		$4K Buy
+1,100
New +$3.56K ﹤0.01% 8441
2025
Q2 		– Sell
-107,700
Closed -$458K – 9712
2025
Q1 		$458K Buy
107,700
+103,500
+2,464% +$462K ﹤0.01% 3481
2024
Q4 		$22K Buy
+4,200
New +$13.6K ﹤0.01% 6621
2024
Q2 		– Sell
-4,100
Closed -$16K – 9795
2024
Q1 		$16K Buy
+4,100
New +$13.2K ﹤0.01% 7288
2023
Q2 		– Sell
-400
Closed -$1K – 9922
2023
Q1 		$1K Sell
400
-500
-56% -$1.65K ﹤0.01% 8777
2022
Q4 		$2K Sell
900
-100
-10% -$316 ﹤0.01% 8655
2022
Q3 		$2K Buy
1,000
+600
+150% +$2.03K ﹤0.01% 9367
2022
Q2 		$1K Sell
400
-2,500
-86% -$9.14K ﹤0.01% 9680
2022
Q1 		$14K Buy
2,900
+2,200
+314% +$11.6K ﹤0.01% 8609
2021
Q4 		$4K Sell
700
-3,600
-84% -$24.8K ﹤0.01% 9714
2021
Q3 		$39K Hold
4,300
– – ﹤0.01% 7834
2021
Q2 		$41K Buy
+4,300
New +$48.7K ﹤0.01% 7898

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Simplex Trading's TARA Position: Q1 2026 in Review

Simplex Trading opened a new position in Protara Therapeutics (TARA) in Q1 2026: 4,449 shares worth $23.2K. The stake represents ﹤0.01% of the portfolio and ranks #6650 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TARA as recently as Q3 2025.

Simplex Trading first reported a position in TARA in Q2 2021 and has held it in 9 quarters since. The position peaked at $77K in Q3 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Simplex Trading held 4,449 shares of Protara Therapeutics worth $23.2K as of Q1 2026.
  • Protara Therapeutics was a new Simplex Trading position in Q1 2026.
  • Protara Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6650 holding.
  • Simplex Trading first reported a position in Protara Therapeutics in Q2 2021 and has held it in 9 quarters since.
  • Simplex Trading's Protara Therapeutics position peaked at $77K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.